Gorham LW, Wright AW, Shultz HH, Maxon FC Jr (1954) Disappearing bones: a rare form of massive osteolysis; report of two cases, one with autopsy findings. Am J Med 17(5):674–682. https://doi.org/10.1016/0002-9343(54)90027-3
Article CAS PubMed Google Scholar
Dellinger MT, Garg N, Olsen BR (2014) Viewpoints on vessels and vanishing bones in Gorham-Stout disease. Bone 63:47–52. https://doi.org/10.1016/j.bone.2014.02.011
Hu P, Yuan XG, Hu XY, Shen FR, Wang JA (2013) Gorham-Stout syndrome in mainland China: a case series of 67 patients and review of the literature. J Zhejiang Univ Sci B 14(8):729–735. https://doi.org/10.1631/jzus.B1200308
Article PubMed PubMed Central Google Scholar
Nikolaou VS, Chytas D, Korres D, Efstathopoulos N (2014) vanishing bone disease (Gorham-Stout syndrome): a review of a rare entity. World J Orthop 5(5):694–698. https://doi.org/10.5312/wjo.v5.i5.694
Article PubMed PubMed Central Google Scholar
Patel DV (2005) Gorham’s disease or massive osteolysis. Clin Med Res 3(2):65–74. https://doi.org/10.3121/cmr.3.2.65
Article PubMed PubMed Central Google Scholar
Homayun-Sepehr N, McCarter AL, Helaers R, Galant C, Boon LM, Brouillard P, Vikkula M, Dellinger MT (2021) KRAS-driven model of Gorham-Stout disease effectively treated with trametinib. JCI Insight. https://doi.org/10.1172/jci.insight.149831
Article PubMed PubMed Central Google Scholar
Nozawa A, Ozeki M, Niihori T, Suzui N, Miyazaki T, Aoki Y (2020) A somatic activating KRAS variant identified in an affected lesion of a patient with Gorham-Stout disease. J Hum Genet 65(11):995–1001. https://doi.org/10.1038/s10038-020-0794-y
Article CAS PubMed Google Scholar
Li MH, Zhang HQ, Lu YJ, Gao P, Huang H, Hu YC, Wang Z (2018) Successful management of Gorham-Stout disease in scapula and ribs: a case report and literature review. Orthop Surg 10(3):276–280. https://doi.org/10.1111/os.12390
Article PubMed PubMed Central Google Scholar
Hopman SM, Van Rijn RR, Eng C, Bras J, Alders M, van der Horst CM, Hennekam RC, Merks JH (2012) PTEN hamartoma tumor syndrome and Gorham-Stout phenomenon. Am J Med Genet A 158A(7):1719–1723. https://doi.org/10.1002/ajmg.a.35406
Rossi M, Buonuomo PS, Battafarano G, Conforti A, Mariani E, Algeri M, Pelle S, D’Agostini M, Macchiaiolo M, De Vito R et al (2020) Dissecting the mechanisms of bone loss in Gorham-Stout disease. Bone 130:115068. https://doi.org/10.1016/j.bone.2019.115068
Article CAS PubMed Google Scholar
Devlin RD, Bone HG 3rd, Roodman GD (1996) Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease. J Clin Endocrinol Metab 81(5):1893–1897. https://doi.org/10.1210/jcem.81.5.8626854
Article CAS PubMed Google Scholar
Falcini F, Ermini M, Bagnoli F (1998) Bone turnover is reduced in children with juvenile rheumatoid arthritis. J Endocrinol Invest 21(1):31–36. https://doi.org/10.1007/BF03347283
Article CAS PubMed Google Scholar
Rossi M, Rana I, Buonuomo PS, Battafarano G, De Martino V, D’Agostini M, Porzio O, Cipriani C, Minisola S, De Vito R et al (2021) Stimulation of treg cells to Inhibit osteoclastogenesis in Gorham-Stout disease. Front Cell Dev Biol 9:706596. https://doi.org/10.3389/fcell.2021.706596
Article PubMed PubMed Central Google Scholar
Komano Y, Nanki T, Hayashida K, Taniguchi K, Miyasaka N (2006) Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts. Arthritis Res Ther 8(5):R152. https://doi.org/10.1186/ar2046
Article CAS PubMed PubMed Central Google Scholar
Feehan J, Nurgali K, Apostolopoulos V, Duque G (2021) Development and validation of a new method to isolate, expand, and differentiate circulating osteogenic precursor (COP) cells. Bone Rep 15:101109. https://doi.org/10.1016/j.bonr.2021.101109
Article CAS PubMed PubMed Central Google Scholar
D’Amelio P, Cristofaro MA, Grimaldi A, Ravazzoli M, Pluviano F, Grosso E, Pescarmona GP, Isaia GC (2010) The role of circulating bone cell precursors in fracture healing. Calcif Tissue Int 86(6):463–469. https://doi.org/10.1007/s00223-010-9362-3
Article CAS PubMed Google Scholar
Suda RK, Billings PC, Egan KP, Kim JH, McCarrick-Walmsley R, Glaser DL, Porter DL, Shore EM, Pignolo RJ (2009) Circulating osteogenic precursor cells in heterotopic bone formation. Stem Cells 27(9):2209–2219. https://doi.org/10.1002/stem.150
Heffez L, Doku HC, Carter BL, Feeney JE (1983) Perspectives on massive osteolysis report of a case and review of the literature. Oral Surg Oral Med Oral Pathol 55(4):331–343. https://doi.org/10.1016/0030-4220(83)90185-8
Article CAS PubMed Google Scholar
Rana I, Buonuomo PS, Mastrogiorgio G, Del Fattore A, Jenkner A, Barbuti D, De Vito R, Pizzoferro M, Callea M, Crostelli M et al (2021) Expanding the spectrum of Gorham Stout disease exploring a single center pediatric case series. Lymphology 54(4):182–194
Rossi M, Rana I, Buonuomo PS, Battafarano G, Mariani E, D’Agostini M, Porzio O, De Martino V, Minisola S, Macchiaiolo M et al (2021) Dysregulated miRNAs in bone cells of patients with Gorham-Stout disease. FASEB J. https://doi.org/10.1096/fj.202001904RR
Gossiel F, Hoyle C, McCloskey EV, Naylor KE, Walsh J, Peel N, Eastell R (2016) The effect of bisphosphonate treatment on osteoclast precursor cells in postmenopausal osteoporosis: the TRIO study. Bone 92:94–99. https://doi.org/10.1016/j.bone.2016.08.010
Article CAS PubMed Google Scholar
Meirow Y, Jovanovic M, Zur Y, Habib J, Colombo DF, Twaik N, Ashkenazi-Preiser H, Ben-Meir K, Mikula I Jr, Reuven O et al (2022) Specific inflammatory osteoclast precursors induced during chronic inflammation give rise to highly active osteoclasts associated with inflammatory bone loss. Bone Res 10(1):36. https://doi.org/10.1038/s41413-022-00206-z
Article CAS PubMed PubMed Central Google Scholar
Muto A, Mizoguchi T, Udagawa N, Ito S, Kawahara I, Abiko Y, Arai A, Harada S, Kobayashi Y, Nakamichi Y et al (2011) Lineage-committed osteoclast precursors circulate in blood and settle down into bone. J Bone Miner Res 26(12):2978–2990. https://doi.org/10.1002/jbmr.490
Article CAS PubMed Google Scholar
Root SH, Aguila HL (2021) Novel population of human monocyte and osteoclast progenitors from pluripotent stem cells and peripheral blood. Blood Adv 5(21):4435–4446. https://doi.org/10.1182/bloodadvances.2021004552
Article CAS PubMed PubMed Central Google Scholar
Xue J, Xu L, Zhu H, Bai M, Li X, Zhao Z, Zhong H, Cheng G, Li X, Hu F et al (2020) CD14(+)CD16(-) monocytes are the main precursors of osteoclasts in rheumatoid arthritis via expressing Tyro3TK. Arthritis Res Ther 22(1):221. https://doi.org/10.1186/s13075-020-02308-7
Article CAS PubMed PubMed Central Google Scholar
Deodati A, Fintini D, Levtchenko E, Rossi M, Ubertini G, Segers H, Battafarano G, Cappa M, Del Fattore A (2022) Mechanisms of acute hypercalcemia in pediatric patients following the interruption of denosumab. J Endocrinol Invest 45(1):159–166. https://doi.org/10.1007/s40618-021-01630-4
Article CAS PubMed Google Scholar
Mun SH, Park PSU, Park-Min KH (2020) The M-CSF receptor in osteoclasts and beyond. Exp Mol Med 52(8):1239–1254. https://doi.org/10.1038/s12276-020-0484-z
Article CAS PubMed PubMed Central Google Scholar
Kodama H, Yamasaki A, Nose M, Niida S, Ohgame Y, Abe M, Kumegawa M, Suda T (1991) Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J Exp Med 173(1):269–272. https://doi.org/10.1084/jem.173.1.269
Article CAS PubMed Google Scholar
Lee KH, Lee KJ, Kim TY, Hutomo F, Sun HJ, Cheon GJ, Park SI, Cho SW, Im SA (2020) Circulating osteocalcin-positive cells as a novel diagnostic biomarker for bone metastasis in breast cancer patients. J Bone Miner Res 35(10):1838–1849. https://doi.org/10.1002/jbmr.4041
Article CAS PubMed Google Scholar
Gossl M, Modder UI, Atkinson EJ, Lerman A, Khosla S (2008) Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis. J Am Coll Cardiol 52(16):1314–1325. https://doi.org/10.1016/j.jacc.2008.07.019
留言 (0)